Gynaecological Oncology Flashcards

1
Q

Which HPV subtypes are most commonly associated with cancer?

A

16 and 18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which HPV subtypes are most commonly associated with genital warts?

A

6 and 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is HPV transmitted?

A

Skin to skin contact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Who gets HPV vaccine?

A

All girls aged 12-13 - three injections over 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How often is cervical screening done?

A
25-49 = every 3 years
50-64 = every 5 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is cervical screening done?

A

Liquid based cytology

Plastic broom swept over the transformation zone aiming to remove thin layer of cells. This is placed in liquid transport medium to be examined microscopically for any cells with dyskaryotic features. HPV test also done.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does high-grade dyskaryosis mean?

A

Reduced ratio of nucleus to cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is colposcopy?

A

Examination of cervix with bright light and magnification to identify any abnormal areas – cervical intraepithelial neoplasia (CIN I, II and III)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is done and identified in colposcopy?

A

Whole transformation zone should be identified.

o 5% Acetic acid – CIN cells appear white – these areas biopsied.
o Lugol’s solution – Schiller’s test – less well taken up by CIN cells
o Abnormal capillary patterns- punctuation, mosaicism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What action is taken if borderline/mild dyskaryosis is found at smear

A

HPV test

if +ve –> colposcopy
if -ve –> normal recall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What action is taken if moderate or severe dyskaryosis is found at smear

A

Straight to colposcopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Definition of CIN I, II and III?

A
I = dyskaryosis 1/3 thickness of cervix
II = dyskaryosis 2/3 thickness of cervix
III = dyskaryosis full thickness of cervix
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is CIN managed?

A

I = Treatment vs no treatment

II/III = LLETZ – large loop excision of the transformation zone. Mostly performed in clinic under local anaesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most common types of cervical cancer?

A

Squamous cell carcinomas or adenocarcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Features of cervical cancer?

A
  • Post-coital bleeding, inter-menstrual bleeding and postmenopausal bleeding
  • Persistent, offensive, blood-stained discharge
  • Pain in late disease - loin (obstructed ureter), buttock and back- metastatic (compression by mass)
  • Swollen leg- thrombosis in the pelvis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examination in cervical cancer?

A
  • Speculum examination
  • Bimanual examination
  • PR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Investigations in cervical cancer?

A
  • Colposcopy
  • Cervical biopsy
  • FBC, U&Es, LFTs
  • MRI pelvis
  • CT abdomen and chest (or CXR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Direct/local spread of cervical cancer?

A

Vagina, bladder, parametrium, bowel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lymphatic spread of cervical cancer?

A

Parametrial nodes, internal, external and common illiac nodes, obturator nodes, pre-sacral, para-aortic nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Bloodborne spread of cervical cancer?

A

Lungs, liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Staging of cervical cancer?

A

FIGO staging

0 = in situ
I = confined to cervix
II = beyond cervix but not to pelvic wall or lower 1/3 of vagina
III = disease in pelvic wall  or lower 1/3 of vagina
IV = invades bladder, rectum or metastasis
22
Q

What does cervical cancer treatment depend on?

A

Depends on stage, desire for future fertility, and concurrent medical conditions

23
Q

Treatment of cervical cancer in early stages when future fertility desired?

A

Repeat cone biopsy with laparoscopic pelvic nodes dissection.

24
Q

Treatment of cervical cancer up to stage 2a?

A

Surgical treatment
 LETZ/conisation
 Radical hysterectomy
 Trachelectomy (simple/radical)

25
Q

Cervical cancer treatment stage 2a and above?

A

Chemoradiotherapy

26
Q

What is the most common gynae cancer?

A

Endometrial

27
Q

Risk factors for endometrial cancer?

A
  • Obesity (~1/3 of all cases)
  • Diabetes
  • Sedentary life-style (23% reduction in risk in active women)
  • Menstrual factors: early menarche, late menopause, low parity
  • Anovulatory amenorrhoea, e.g. PCOS • Unopposed oestrogen HRT
  • Oestrogen-secreting ovarian tumours
  • Tamoxifen
  • FH of colorectal, endometrial or breast cancer
  • Smoking slightly reduces the risk
28
Q

How does endometrial hyperplasia occur?

A
  • Subcutaneous fat produces oestrogen post-menopausally owing to aromatisation of adrenal steroids oestrogenic effect on endometrium without protection of progesterone.
  • Unopposed oestrogen –> hyperplasia
29
Q

What can endometrial hyperplasia lead to?

A

Hyperplasia predisposes to cytological atypia (simple, complex, atypical)

Atypical hyperplasia is precancerous and develops into invasive cancer 10-50% over 20 years

30
Q

Management of endometrial hyperplasia?

A

 Simple and complex - progesterone treatment

 Atypical - hysterectomy

31
Q

Most common type of endometrial cancer?

A

Adenocarcinoma is commonest (90%) – endometrioid type

32
Q

Clinical features of endometrial cancer?

A

Postmenopausal bleeding (PMB) = endometrial ca until proven otherwise - 10% of women with PMB will have a malignancy

Premenopausal women – irregular, heavy or inter-menstrual bleeding especially if < 40 years old

33
Q

Examination in endometrial cancer?

A

Speculum
• To exclude other causes such as cervical or vaginal lesions
PV
• Fixed or bulky uterus occurs with advanced disease

34
Q

Investigations in endometrial cancer?

A
  • TV USS with endometrial thickness
  • Biopsy
  • Pipelle in clinic
  • Hysteroscopy and biopsy (>4mm)
  • MRI – depth of invasion, cervical involvement, lymphadenopathy
  • CT abdomen and chest if high-risk cancer, e.g. sarcoma
35
Q

Why does endometrial cancer have a good prognosis?

A

The myometrium acts as a barrier to spread of the cancer – early presentation and high cure rate

36
Q

Where does endometrial cancer spread to?

A
  • Direct – cervical stroma, fallopian tubes and ovaries
  • Across peritoneal cavity to omentum, surface of other organs – liver, bowel
  • Lymphatic – pelvic, para-aortic and rarely inguinal lymph nodes
  • Blood-borne – liver, lungs
37
Q

Staging of endometrial cancer?

A

Stage I Confined to body of uterus

Stage II Involving the cervix

Stage III Spread outside the uterus

Stage IV With bowel, bladder or distant organ involvement

38
Q

Management of endometrial cancer (early stage)?

A

Total hysterectomy, bilateral salpingo-oophorectomy, peritoneal washings

39
Q

Management of endometrial cancer (late stage)?

A

Staging laparotomy/laparoscopic staging

40
Q

Management of endometrial cancer (advanced stage)?

A

Chemoradiotherapy/ NACT/ Hormone therapy

41
Q

Where does ovarian cancer rank in diagnosis in women, gynae cancers and gynae cancer death

A

5th most common cancer in women

2nd most common gynae cancer

Most common cause of gynae cancer death

42
Q

Risk factors for ovarian cancer

A
  • Nulliparity
  • HRT
  • Endometriosis
  • Difficulties conceiving
  • 5-10% of patients with epithelial ovarian cancer have a genetic predisposition: BRCA1 and BRCA2 gene mutations
43
Q

Why does nulliparity increase risk of cervical cancer?

A

o Increased ovulation puts trauma on the follicle as it must rupture and repair more times
o Contraception that stops ovulation is beneficial

44
Q

Histopathology of ovarian cancers?

A
  • Epithelial – derived from Mullerian epithelium
  • Sex cord or stromal – derived from ovarian stroma, sex cord derivatives or both
  • Germ cell – derived from ovarian germ cells
45
Q

When do ovarian cancers tend to present?

A

Usually present very late (stage 3 or 4)

46
Q

History in ovarian cancer?

A
  • Abdominal pain and swelling
  • Pressure effects on the bladder and rectum
  • Dyspnoea
  • Gastrointestinal upset and anorexia
  • Abnormal vaginal bleeding
  • Up to 15% of patients will remain asymptomatic at diagnosis
47
Q

Examination in ovarian cancer?

A
  • Adnexal or pelvic mass
  • Shifting dullness
  • Irregular abdominal mass – omental cake
48
Q

Investigations in ovarian cancer?

A
  • Pelvic USS
  • Tumour Markers
  • Chest X-ray
  • FBC, U&Es, LFTs
  • CT abdomen and pelvis
  • Paracentesis of ascites
49
Q

Tumour markers in ovarian cancer?

A

o CA125 – Serous, endometrioid
o CA19.9 – Mucinous
o Carcinoembryonic antigen – CEA
o AFP, HCG, LDH

50
Q

Staging of ovarian cancer?

A

Stage I Limited to one or both ovaries

Stage II Pelvic extension or implants

Stage III Microscopic peritoneal implants outside of the pelvis; or limited to the pelvis with extension to the small bowel or omentum

Stage IV Distant metastases

51
Q

Treatment of ovarian cancer?

A
  • Total abdominal hysterectomy, bilateral salpingoophretcomy, omentectomy, lymph node sampling and peritoneal biopsies with peritoneal washings or ascitic fluid obtained for cytology
  • Adjuvant chemotherapy with platinum based compounds has been shown to benefit women with no residual disease following surgery, improving survival (ICON 1)